Browse EX-10 agreements

AMENDMENT NO. 8

TO TRANSITION SERVICES AGREEMENT

This Amendment No. 8 (“Amendment No. 8”) to the Agreement (as defined below) is made effective as of April 29, 2026 (the “Effective Date”) by and among BridgeBio Services Inc., a Delaware corporation (“BBIO”), TheRas, Inc., a Delaware corporation (“BBOT”), BridgeBio Pharma LLC (“BBP LLC”), and BridgeBio Oncology Therapeutics, Inc. (“PubCo”). BBIO, BBOT, BBP LLC and PubCo may be referred to herein by name or individually, as a “Party” and collectively, as the “Parties.” Capitalized terms used and not otherwise defined herein shall have the meanings given such terms in the Agreement (as defined below) to the extent defined therein.

WHEREAS, BBIO and BBOT entered into that certain Transition Services Agreement, dated April 30, 2024, as amended (the “Agreement”);

WHEREAS, the Agreement was subsequently amended to add BBP LLC and PubCo as Parties to the Agreement; and

WHEREAS, the Parties now wish to further amend the Agreement to update the Service Schedule on Exhibit A thereto.

NOW, THEREFORE, in consideration of the covenants, conditions and undertakings hereinafter set forth, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties hereby agree as follows:

Amendment to Service Schedule. Exhibit A of the Agreement is hereby amended to add the following Human Resources Services:

…

CERTAIN INFORMATION CONTAINED IN THIS EXHIBIT, MARKED BY [***], HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE THE REGISTRANT HAS DETERMINED THAT IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

Exhibit 10.2

LEIDOS BIOMEDICAL

COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT

This Cooperative Research and Development Agreement (“CRADA” or “Agreement”) has been adopted for use by the Frederick National Laboratory for Cancer Research (FNLCR), a Federally Funded Research and Development Center (FFRDC) and a Federal Laboratory operated by Leidos Biomedical Research, Inc., under the Operations and Technical Support (OTS) Contractor.

This Cover Page identifies the Parties to this Agreement:

Frederick National Laboratory for Cancer Research (FNLCR)

Operated by Leidos Biomedical Research, Inc.

hereinafter referred to as “Leidos Biomedical”,

having offices at 1050 Boyles Street, Frederick, Maryland 21702,

created and operating under the laws of Delaware

and

TheRas

hereinafter referred to as the “Collaborator”,

having offices at 165 University Ave, Suite 5, Palo Alto, 94301,

created and operating under the laws of Delaware.

CRADA TITLE: Development and characterization of KRas targeting compounds

CRADA NUMBER: 10056-16

Article 1.

Introduction

…

CERTAIN INFORMATION CONTAINED IN THIS EXHIBIT, MARKED BY [***], HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE THE REGISTRANT HAS DETERMINED THAT IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

Exhibit 10.1

STEVENSON-WYDLER (15 USC 3710a)

COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT

Between

LAWRENCE LIVERMORE NATIONAL SECURITY, LLC

and

THERAS, INC.

For

DISCOVERY OF NOVEL RAS INHIBITORS

LLNL Case No. TC02290.0

Lawrence Livermore National Laboratory

Lawrence Livermore National Security, LLC, Livermore, CA 94551

Innovation and Partnerships Office

May 8, 2018

---

TABLE OF CONTENTS

		Page
Article I:	DEFINITIONS	1
Article II:	STATEMENT OF WORK, TERM, FUNDING AND COSTS	3
Article III:	PERSONAL PROPERTY	4
Article IV:	DISCLAIMER	4
Article V:	PRODUCT LIABILITY	5
Article VI:	RIGHTS IN SUBJECT INVENTIONS	6
Article VII:	RIGHTS IN DATA	7
Article VIII:	U.S. COMPETITIVENESS	12
Article IX:	EXPORT CONTROL	12
Article X:	REPORTS AND PUBLICATIONS	12
Article XI:	FORCE MAJEURE	13
Article XII:	DISPUTES	13
Article XIII:	ENTIRE CRADA AND MODIFICATIONS	14
Article XIV:	TERM AND TERMINATION	14
Article XV:	LABORATORY SITE ACCESS SAFETY AND HEALTH	15
Article XVI:	SIMILAR OR IDENTICAL SERVICES	15
Article XVII:	ASSIGNMENT OF PERSONNEL	15
Article XVIII:	MISCELLANEOUS	16
Appendix A	Statement of Work	App A.1

…

SECURITIES CANCELLATION AGREEMENT

This Securities Cancellation Agreement (this “Agreement”), dated as of May 8, 2026, is entered into by and between The Lucerne Capital Master Fund, L.P., a Cayman Islands limited partnership (the “Securities Holder”), and ADS-TEC Energy PLC, a public limited company incorporated in Ireland (the “Company”).

RECITALS

WHEREAS, pursuant to that certain Securities Purchase Agreement, dated as of April 2, 2026, by and between the Securities Holder and AIMF SPV LLC, a Texas limited liability company (“AIMF SPV”), the Securities Holder acquired warrants (the “AIMF Warrants”) to acquire, after adjustment, 712,641 Ordinary Shares, par value $0.01 per share (“Ordinary Shares”), of the Company at an exercise price of $10.31 per Ordinary Share, together with all of the Securities Holder’s rights under the Securities Purchase Agreement, dated as of May 1, 2025, between the Company on the one part and AIMF SPV, AEMF SPV and AOMF SPV on the other part (the “May 2025 SPA”) and the other Transaction Documents (as defined therein), for an aggregate purchase price of $4,289,999.21 (the “AIMF Purchase Price”);

…

[Exhibit B]

FORM OF REGISTRATION RIGHTS AGREEMENT

This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of [●], by and among (i) ads-tec Energy PLC, a public limited company incorporated under the laws of Ireland (the “Company”), and (ii) the parties listed on Schedule A hereto (each such party, together with any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.2 of this Agreement or the Joinder Agreement, a “Holder” and collectively, the “Holders”). Certain capitalized terms used and not otherwise defined herein are defined in Article 1 hereof.

RECITALS

WHEREAS, pursuant to one or more subscription agreements (each, a “Subscription Agreement”) with certain investors, the Company has agreed to provide the Holders with certain registration rights with respect to the Ordinary Shares issued or issuable thereunder (the “Subscription Shares”); and

WHEREAS, the parties hereto desire to enter into this Agreement to set forth the registration rights of the Holders on the terms and subject to the conditions set forth herein.

NOW, THEREFORE, in consideration of the mutual representations, covenants and agreements contained herein, and certain other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:

Article 1. DEFINITIONS

…

THIS SUBSCRIPTION AGREEMENT (THIS “AGREEMENT”) RELATES TO AN OFFER AND SALE OF SECURITIES IN AN OFFSHORE TRANSACTION TO A PERSON WHICH IS NOT A U.S. PERSON (AS DEFINED HEREIN) PURSUANT TO REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”).

NONE OF THE SECURITIES TO WHICH THIS SUBSCRIPTION AGREEMENT RELATES HAVE BEEN REGISTERED UNDER THE SECURITIES ACT, OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED, NONE MAY BE OFFERED OR SOLD, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OR TO U.S. PERSONS (AS DEFINED HEREIN) EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S UNDER THE SECURITIES ACT, PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN EACH CASE ONLY IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.

SUBSCRIPTION AGREEMENT

…

THIS SUBSCRIPTION AGREEMENT (THIS “AGREEMENT”) RELATES TO THE OFFER AND SALE OF SHARES BY THE ISSUER IN A TRANSACTION NOT INVOLVING ANY PUBLIC OFFERING IN RELIANCE UPON THE EXEMPTION FROM REGISTRATION PROVIDED BY SECTION 4(A)(2) OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”).

THE SHARES TO WHICH THIS SUBSCRIPTION AGREEMENT RELATES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OR ANY APPLICABLE U.S. STATE SECURITIES LAWS AND ARE BEING OFFERED AND SOLD BY THE ISSUER IN RELIANCE UPON THE EXEMPTION FROM REGISTRATION PROVIDED BY SECTION 4(A)(2) OF THE SECURITIES ACT. THE SHARES CONSTITUTE “RESTRICTED SECURITIES” AND MAY NOT BE OFFERED, SOLD, PLEDGED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND, IN EACH CASE, IN COMPLIANCE WITH APPLICABLE STATE SECURITIES LAWS.

SUBSCRIPTION AGREEMENT

…

EXHIBIT A

EXERCISE NOTICE

To:	ads-tec Energy PLC, an Irish public limited company (the “Irish Guarantor”)

Dated: April 15, 2026

The undersigned, pursuant to the provisions set forth in that certain Amended and Restated Warrant, dated as of August 26, 2024, and amended with the Warrant Adjustment Notice dated April 9, 2026, by and between the Irish Guarantor and the Lender (the “Warrant”), hereby irrevocably elects to subscribe for 66,666 Warrant Shares covered by such Warrant and herewith makes payment of $66,666 representing the full exercise price for such Warrant Shares at the price of $1.00 per Warrant Share. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Warrant.

The undersigned acknowledges that it has reviewed the representations and warranties set forth as Annex I to this Exercise Notice, which representations and warranties are incorporated herein by reference and by its signature below hereby makes such representations and warranties to the Irish Guarantor.

ACKNOWLEDGED AND AGREED TO BY THE LENDER:
The Lucerne Capital Special Opportunity Fund, Ltd.
By:	/s/ Pieter Taselaar
Name:	Pieter Taselaar
Title:	Director

Address: 73 Arch Street, 3rd Floor, Greenwich, CT 06830

Telephone: 203-983-4470

Fax: 203-983-4401

Email: pmoroney@lucernecap.com

Annex I

…

EXHIBIT A

EXERCISE NOTICE

To: ads-tec Energy PLC, an Irish public limited company (the “Irish Guarantor”)

Dated: April 10, 2026

The undersigned, pursuant to the provisions set forth in that certain Amended and Restated Warrant, dated as of August 26, 2024, and amended with the Warrant Adjustment Notice dated April 9, 2026, by and between the Irish Guarantor and the Lender (the “Warrant”), hereby irrevocably elects to subscribe for 5,105,379 Warrant Shares covered by such Warrant and herewith makes payment of $5,105,379 representing the full exercise price for such Warrant Shares at the price of $1.00 per Warrant Share. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Warrant.

The undersigned acknowledges that it has reviewed the representations and warranties set forth as Annex I to this Exercise Notice, which representations and warranties are incorporated herein by reference and by its signature below hereby makes such representations and warranties to the Irish Guarantor.

ACKNOWLEDGED AND AGREED TO BY

THE LENDER:

The Lucerne Capital Master Fund, L.P.
By:	/s/ Pieter Taselaar
Name:	Pieter Taselaar
Title:	Director

Address: 73 Arch Street, 3rd Floor, Greenwich, CT 06830

Telephone: 203-983-4470

Fax: 203-983-4401

Email: pmoroney@lucernecap.com

Annex I

…

Exhibit 10.1

ads-tec Energy plc, 10 Earlsfort Terrace, D02 T380 Dublin 2

9 April 2026

Via Email and Overnight Courier

To:

Lucerne Capital Master Fund L.P. 73 Arch Street, 3rd floor Greenwich, CT 06830 United States of America E-Mail: pmoroney@lucernecap.com

(the Warrantholder)

CC:

ads-tec Energy GmbH Heinrich-Hertz-Straße 1 72622 Nürtingen, Germany

Arthur Cox LLP

Dublin 2, D02 T380 Ireland Attention: Connor Manning Email: connor.manning@arthurcox.com Re: Company Warrant Adjustment Notice

Ladies and Gentlemen:

We refer to each Warrant, dated as of 26 August 2024, by and among ADS-Tec Energy PLC (the company) and the applicable Warrantholder (each, a ”Warrant” and together, the “Warrants”). Unless otherwise specified herein, capitalized terms used but not defined in this letter have meanings given in the Warrants.

Pursuant to Section 3(a) and 3(b) of the Warrants and subject to the terms of this letter, the Company hereby provides notice to each Warrantholder and the Transfer Agent that as of the date hereof, the Exercise Price of the Warrants has been adjusted to $1.00 per Warrant and the number of Warrant Shares issuable upon the exercise of each Warrant has been adjusted, as set forth with respect to each Warrantholder on Annex A hereto.

IN WITNESS WHEREOF, the undersigned has executed this notice as of the date first written above.

	ADS-TEC Energy PLC
	By:	/s/ Torsten Klee
	Name:	Torsten Klee
	Title:	Chief Financial Officer

2

Annex A

Warrant Adjustment

…

VOTING AND SUPPORT AGREEMENT

THIS VOTING AND SUPPORT AGREEMENT (this “Agreement”) is entered into as of May 12, 2026, by and among BROOKFIELD BANCSHARES, INC., a Delaware corporation (“Purchaser”), and those directors and/or officers of NSTS BANCORP, INC., a Delaware corporation (the “Company”) whose names appear on the signature page of this Agreement and who own or control the voting of any shares of common stock of the Company (such stockholders collectively referred to in this Agreement as the “Principal Stockholders,” and individually as a “Principal Stockholder”).

Recitals

A.           As of the date hereof, each Principal Stockholder is the owner or controls the vote of certain shares of the Company’s common stock, $0.01 par value per share (“Company Common Stock”).

B.          Purchaser is contemplating the acquisition of the Company by means of a merger (the “Merger”) of a wholly-owned subsidiary of Purchaser with and into the Company, all pursuant to an Agreement and Plan of Merger, dated as of May 12, 2026 (the “Merger Agreement”), by and among Purchaser, the Company and BRKD Merger Sub Inc., a Delaware corporation and wholly-owned subsidiary of Purchaser.

C.           As a condition and inducement for Purchaser to enter into the Merger Agreement, each Principal Stockholder is entering into this Agreement.

D.           Each Principal Stockholder believes it is in his or her best interest as well as the best interest of the Company for Purchaser and the Company to consummate the Merger.

…

CREDIT AGREEMENT

Dated as of May 12, 2026

among

SOLARIS ENERGY INFRASTRUCTURE, LLC,

as the Borrower,

SOLARIS ENERGY INFRASTRUCTURE, INC.,

as Parent

MUFG BANK, LTD.,

as Administrative Agent,

CSC DELAWARE TRUST COMPANY,

as Collateral Agent,

and

THE LENDERS AND L/C ISSUERS PARTY HERETO FROM TIME TO TIME

MUFG BANK, LTD., BANCO SANTANDER, S.A., NEW YORK BRANCH, CANADIAN IMPERIAL BANK OF COMMERCE, NEW YORK BRANCH, GOLDMAN SACHS BANK USA, MORGAN STANLEY SENIOR FUNDING, INC.

and

TD SECURITIES (USA) LLC

as Joint Lead Arrangers and Joint Bookrunners

---

TABLE OF CONTENTS

				Page
ARTICLE I DEFINITIONS AND ACCOUNTING TERMS					1
Section 1.01.		Defined Terms			1
Section 1.02.		Other Interpretive Provisions			54
Section 1.03.		Accounting Terms			55
Section 1.04.		Rounding			55
Section 1.05.		References to Agreements, Laws, Etc.			56
Section 1.06.		Times of Day			56
Section 1.07.		Timing of Payment or Performance			56
Section 1.08.		[Reserved]			56
Section 1.09.		Certain Calculations and Tests			56
Section 1.10.		[Reserved]			58
Section 1.11.		Letter of Credit Amounts			58
Section 1.12.		Divisions			58
Section 1.13.		[Reserved]			58
Section 1.14.		Interest Rates			58

…